From May 8, 2023 to June 30, 2023, the company has repurchased 10,000,000 shares, representing 1.3% for CNY 70.46 million. With this, the company has completed the repurchase of 10,000,000 shares, representing 1.3% for CNY 70.46 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.58 CNY | -1.50% | -2.66% | -4.64% |
1st Jan change | Capi. | |
---|---|---|
-4.64% | 66Cr | |
+21.88% | 4.42TCr | |
+23.03% | 2.3TCr | |
+19.99% | 1.53TCr | |
+12.33% | 1.37TCr | |
+50.52% | 1.22TCr | |
-10.02% | 683.92Cr | |
-0.05% | 678.76Cr | |
-8.87% | 572.55Cr | |
+13.88% | 565.87Cr |
- Stock Market
- Equities
- 600351 Stock
- News Yabao Pharmaceutical Group Co., Ltd
- Tranche Update on Yabao Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on May 9, 2023.